Recent News

• 02.06.2026 - CMS Maintains NOPAIN Act Eligibility for ON‑Q* and ambIT* Infusion Pumps; Adds Game Ready* in 2026
• 01.20.2026 - A Clear Vision for Avanos: Purpose, Focus and Growth in 2026 and Beyond
• 12.10.2025 - From Strategy to the CFO Seat: Lessons from My Journey
• 11.11.2025 - With Thanks and Gratitude on Veterans Day
• 11.06.2025 - Doing the Right Things the Right Way: Finding Our “Fast Car” Through Collaboration
• 11.05.2025 - Avanos Medical, Inc. Announces Third Quarter 2025 Results
• 10.27.2025 - Avanos Medical, Inc. to Webcast Conference Call Discussing Third Quarter 2025 Financial Results
• 10.09.2025 - What the Future of Healthcare Needs from Us

Recent Filings

• 01.21.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.13.2026 - 8-K Current report
• 01.13.2026 - EX-99.1 EX-99.1
• 12.05.2025 - 8-K/A Current report
• 11.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.18.2025 - 144 Report of proposed sale of securities
• 11.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 11.05.2025 - EX-99.1 EX-99.1
• 11.05.2025 - 8-K Current report
• 11.05.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]